Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Hsiang Lin

Showing results (221-230 of 231) with videos related to

Pageof 24
Sort By:
Acta Diabetologica|May 24, 2024
Association between sodium-glucose cotransporter-2 (SGLT2) inhibitors and macular degeneration in patients with diabetes: a nationwide population-based study in TaiwanMin-Yen Hsu, Kai-Shin Luo, Chien-Chih Chou, et al.
Neurology. Genetics|May 18, 2026
Genetic Risk Factors for Intracerebral Hemorrhage in Populations of East Asian AncestryYu-Chung Juan, John S Kuo, Hung-Lin Chen, et al.
Health Information Management : Journal of the Health Information Management Association of Australia|November 4, 2025
Automating cancer registries: Pearls and pitfallsShrirajh Satheakeerthy, Mark Beecher, Andrew Ec Booth, et al.
BMC Cancer|March 3, 2026
Circulating tumor cells (CTCs) enumeration and machine-learning based diagnostic biomarkers for breast cancer detectionChun-Yu Liu, Yu-Hsiang Lin, Yi-Fang Tsai, et al.
Journal of Robotic Surgery|July 10, 2025
Predicting hemorrhagic complications in robotic-assisted partial nephrectomy for renal tumors: simplifying risk assessment with tumor diameter and depthI-Hung Shao, Chung-Lin Lee, Yu-Hsiang Lin, et al.
Cancer Research|December 6, 2014
H3K9 histone methyltransferase, KMT1E/SETDB1, cooperates with the SMAD2/3 pathway to suppress lung cancer metastasisPei-Chun Wu, Jeng-Wei Lu, Jer-Yen Yang, et al.
Journal of Medicinal Chemistry|April 30, 2014
Discovery of 4-aryl-N-arylcarbonyl-2-aminothiazoles as Hec1/Nek2 inhibitors. Part I: optimization of in vitro potencies and pharmacokinetic propertiesYing-Shuan E Lee, Shih-Hsien Chuang, Lynn Y L Huang, et al.
Journal of Medicinal Chemistry|August 5, 2010
Discovery of pyrrole-indoline-2-ones as Aurora kinase inhibitors with a different inhibition profileChao-Cheng Chiang, Yu-Hsiang Lin, Shu Fu Lin, et al.
European Journal of Medicinal Chemistry|November 4, 2010
Synthesis and structure-activity relationship of 3-O-acylated (-)-epigallocatechins as 5α-reductase inhibitorsShu Fu Lin, Yu-Hsiang Lin, Mengju Lin, et al.
European Journal of Medicinal Chemistry|March 1, 2020
Discovery of T-1101 tosylate as a first-in-class clinical candidate for Hec1/Nek2 inhibition in cancer therapyShih-Hsien Chuang, Ying-Shuan E Lee, Lynn Y L Huang, et al.
Pageof 24

Showing results (221-230 of 231) with videos related to

Sort By:
Pageof 24
Acta Diabetologica|May 24, 2024
Association between sodium-glucose cotransporter-2 (SGLT2) inhibitors and macular degeneration in patients with diabetes: a nationwide population-based study in TaiwanMin-Yen Hsu, Kai-Shin Luo, Chien-Chih Chou, et al.
Neurology. Genetics|May 18, 2026
Genetic Risk Factors for Intracerebral Hemorrhage in Populations of East Asian AncestryYu-Chung Juan, John S Kuo, Hung-Lin Chen, et al.
Health Information Management : Journal of the Health Information Management Association of Australia|November 4, 2025
Automating cancer registries: Pearls and pitfallsShrirajh Satheakeerthy, Mark Beecher, Andrew Ec Booth, et al.
BMC Cancer|March 3, 2026
Circulating tumor cells (CTCs) enumeration and machine-learning based diagnostic biomarkers for breast cancer detectionChun-Yu Liu, Yu-Hsiang Lin, Yi-Fang Tsai, et al.
Journal of Robotic Surgery|July 10, 2025
Predicting hemorrhagic complications in robotic-assisted partial nephrectomy for renal tumors: simplifying risk assessment with tumor diameter and depthI-Hung Shao, Chung-Lin Lee, Yu-Hsiang Lin, et al.
Cancer Research|December 6, 2014
H3K9 histone methyltransferase, KMT1E/SETDB1, cooperates with the SMAD2/3 pathway to suppress lung cancer metastasisPei-Chun Wu, Jeng-Wei Lu, Jer-Yen Yang, et al.
Journal of Medicinal Chemistry|April 30, 2014
Discovery of 4-aryl-N-arylcarbonyl-2-aminothiazoles as Hec1/Nek2 inhibitors. Part I: optimization of in vitro potencies and pharmacokinetic propertiesYing-Shuan E Lee, Shih-Hsien Chuang, Lynn Y L Huang, et al.
Journal of Medicinal Chemistry|August 5, 2010
Discovery of pyrrole-indoline-2-ones as Aurora kinase inhibitors with a different inhibition profileChao-Cheng Chiang, Yu-Hsiang Lin, Shu Fu Lin, et al.
European Journal of Medicinal Chemistry|November 4, 2010
Synthesis and structure-activity relationship of 3-O-acylated (-)-epigallocatechins as 5α-reductase inhibitorsShu Fu Lin, Yu-Hsiang Lin, Mengju Lin, et al.
European Journal of Medicinal Chemistry|March 1, 2020
Discovery of T-1101 tosylate as a first-in-class clinical candidate for Hec1/Nek2 inhibition in cancer therapyShih-Hsien Chuang, Ying-Shuan E Lee, Lynn Y L Huang, et al.
Pageof 24